How to Buy Sarepta Therapeutics Stock

Step 1: Decide where to buy Sarepta Therapeutics stock

You will need a brokerage account to access the NASDAQ market and buy SRPT stock.

Step 2: Open a brokerage account

Now that you've selected the right brokerage, you'll need to fill out some personal information so you can invest in SRPT stock today.

How to Open a New Investment Account on eToro

1. Click here to get started.
   eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
2. Enter your personal data to create your new brokerage account.

3. Submit your info by clicking the "Create Account" button.
Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you've filled out your info on the best stock trading app, you need to deposit funds:

Check out the video below to see the process of transferring funds into your investment account.

Step 4: Analyze Sarepta Therapeutics stock

After you have figured out the best place to buy Sarepta Therapeutics stock, it's very important to research their stock before you buy, so you truly understand the risk as well as the opportunity.

Sarepta Therapeutics quick stats

Fundamentals of Sarepta Therapeutics

WallStreetZen was built to help average investors do better fundamental analysis quickly.

You can see all of the due diligence checks on SRPT's stock page.

Is SRPT stock properly valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge SRPT's intrinsic value.

Using relative valuations methods:

• SRPT may be overvalued based on its P/E ratio of 26.55x, relative to Biotechnology industry P/E ratio of 14.89x
• SRPT could be undervalued based on its P/B ratio of 1.12x, relative to Biotechnology industry P/B ratio of 5.31x

You can access additional valuation research on SRPT's stock here.

SRPT Financial Health Overview

Passed Financial Due Diligence Checks:

• SRPT profit margin has gone up from -11.1% to 3% in the past year.
• There are more short-term assets than short-term liabilities on the SRPT balance sheet.
• Total SRPT debt is lower than 5 years ago, relative to shareholder equity.
• SRPT earnings of $24.47M is not enough to cover its interest payments.
• There are more short-term assets than long-term liabilities on the SRPT balance sheet.

Failed Financial Due Diligence Checks:

• SRPT has a relatively high debt to equity ratio of 1.11.
• SRPT's operating cash flow of $175.28M allows it to safely service it's debt of $1.04B.

Is SRPT stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 7 Equities analysts who give forecasts on SRPT, the consensus analyst rating on SRPT is a Hold

Please note that analyst forecasts are not stock recommendations, nor are they investment advice.

Most Recent SRPT Analyst Ratings

Uy Ear, a top 16% analyst from Mizuho maintains SRPT with a buy rating and raises their SRPT price target from $26.00 to $31.00, on Mar 13, 2026.

Yanan Zhu, a top 18% analyst from Wells Fargo maintains SRPT with a strong buy rating and lowers their SRPT price target from $45.00 to $38.00, on Feb 27, 2026.

You can dig deeper into what analysts are saying on the Sarepta Therapeutics stock forecast page.

SRPT Technicals

SRPT Revenue

Last year, SRPT earnings were $65.06M. During the last two year, SRPT's earnings have grown by 20.97% per year. This was faster than the Biotechnology industry average of 11.14%.

Last year, SRPT revenue was $2.18B. Over the last five year, SRPT's revenue has gone up by 30.67% per year. This was slower than the Biotechnology industry average of 34.26%.

Dig into SRPT's earnings and revenue performance here.

Are SRPT insiders buying or selling the stock?

In the past 12 months, executives and large shareholders at SRPT have sold more shares than they have bought.

Stephen Mayo, Director of SRPT, was the latest SRPT insider to sell. They sold $123,207.78 worth of SRPT shares on Mar 12, 2026.

Get more info about who owns SRPT shares here.

Does SRPT provide a stable income stream?

No, Sarepta Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about SRPT?

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your SRPT trade

You have two primary options:

• Market order: A market order is an order to buy or sell a security at the best possible price.
  Market orders are usually sufficient.
• Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
  If you want to ensure you're buying or selling at an exact price, use a limit order.

Click the Open Trade button and your broker will execute your order.

If you require additional assistance buying stocks on eToro, watch the helpful video below:

Step 6: Keep tabs on your SRPT investment

Now that you own some SRPT shares, you'll want to keep up with your investment.

Put SRPT on a watchlist to keep track of your SRPT stock.

How to Buy Stock in Sarepta Therapeutics

To reiterate, here are the 6 steps you need to take to buy Sarepta Therapeutics stock right now:

1. Decide where to buy Sarepta Therapeutics stock
2. Open a brokerage account
3. Deposit funds into your investment account
4. Analyze Sarepta Therapeutics stock
5. Make your SRPT trade
6. Keep tabs on your SRPT investment

If you require a brokerage account, eToro is our favorite venue.

If you want to get the latest news on your investment in Sarepta Therapeutics, add SRPT to your watchlist below.

Related Content

• How to purchase stock in Tesla
• How to buy WMT stock
• How to purchase stock in Berkshire Hathaway
• How to buy stock in AAPL
• How to purchase Disney stock online
• How to purchase shares in AMZN
• How to buy NFLX
• How to buy stocks
• How to buy Google stock
• How to buy Pfizer stock